FDA Janssen

Showing 1 posts of 1 posts found.


FDA expands approval for Janssen’s Spravato nasal spray to cover major depressive disorder with suicidal ideation

August 4, 2020
Manufacturing and Production FDA Janssen, Spravato, depression

The FDA has moved to expand the existing approval of Janssen’s Spravato (esketamine) CIII nasal spray to include treatment of symptoms …

Latest content